Biomerica (BMRA) Interest & Investment Income (2010 - 2023)

Biomerica has disclosed Interest & Investment Income across 14 years of filings, most recently posting $55632.0 for Q2 2023.

• Interest & Investment Income for Q2 2023 came in at $55632.0, up 666.28% year-over-year; the trailing twelve-month figure through May 2023 was $133000.0 (up 392.59% YoY), and the FY2023 annual result was $133000.0, up 392.59% from the prior year.
• Interest & Investment Income came in at $55632.0 for Q2 2023 at Biomerica, up from $36086.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $55632.0 in Q2 2023 to a low of $28.0 in Q3 2022.
• The 5-year median for Interest & Investment Income is $8037.0 (2020), against an average of $18349.1.
• Across the five-year window, Interest & Investment Income soared 7928.73% in 2019 and sank 99.59% in 2022, its largest moves.
• Biomerica's Interest & Investment Income stood at $4488.0 in 2019, then surged by 77.87% to $7983.0 in 2020, then slipped by 13.37% to $6916.0 in 2021, then surged by 496.5% to $41254.0 in 2022, then soared by 34.85% to $55632.0 in 2023.
• The last three Interest & Investment Income figures came in at $55632.0 (Q2 2023), $36086.0 (Q1 2023), and $41254.0 (Q4 2022), per Business Quant data.